Odylia Therapeutics logo

Odylia Therapeutics

Odylia Therapeutics is a nonprofit biotech working to accelerate the development of treatments for people with rare diseases.

9
DonateStart a fundraiser
User or nonprofit avatar
Youth
User or nonprofit avatar
Humans
User or nonprofit avatar
Research
User or nonprofit avatar
Health
User or nonprofit avatar
Science & Technology
User or nonprofit avatar
Disease Prevention

At Odylia, we accelerate therapeutic development for people with rare diseases, changing the way treatments are brought from the lab to the clinic. We strive to bring life altering treatments to people with genetic disease regardless of prevalence or commercial interest.
Odylia is shifting the paradigm to focus on proven science and removing traditional roadblocks. We work to lower costs, reduce development time, focus research, and continuously drive successful programs towards clinical trials and regulatory approval. Strategic collaborations with patient groups, research labs, and commercial partners facilitate our work to ensure treatments are safe, effective, and ultimately reach patients who need them.

Odylia challenges the traditional approach to drug development through:

  1. Lower cost of development
    Lower licensing fees to decrease development costs and ensure continued commitment to program success

  2. Increase speed of development
    Challenge traditional approaches through regulatory engagement

Streamline development through strategic partnerships and a platform approach to drug development

  1. Enable the entire ecosystem Provide expertise through in-house Brydge Solutions and leveraging the Odylia Board

Enable the entire ecosystem through Initiatives that impact the broader field

Atlanta, GA
Small organization
odylia.org
A 501(c)(3) nonprofit, EIN 82-2120760

Fundraisers

Feed fundraiser card link to His future is bright - help keep his vision clear
Odylia Therapeutics logo
Fundraiser by Leon Nabuurs
a lively boy

His future is bright - help keep his vision clear

This is Rem Nabuurs Kim, born on the last day of 2023. He is a very lively boy who radiates a zest for life and shares it with everyone around him. Unfortunately, he has a visual impairment. His sight is poor due to a rare genetic disorder, and without available treatment his vision will likely continue to deteriorate. There is currently no cure for this condition — Leber Congenital Amaurosis (LCA) caused by a mutation in the RGRIP1 gene — yet Odylia Therapeutics, a non‑profit organization in the United States, is working hard on a solution. The progress of their research is promising, but it still depends on sufficient funding. Only with an adequate budget can the full development process be completed and the gene therapy become available — not just for Rem, but for everyone affected by this mutation. That’s why we kindly ask you to contribute to this research. Let’s hope this will help Rem preserve, or even improve, his vision! Thank you in advance for your support, on behalf of Rem and his family. If you would like to learn more about LCA/RGRIP1 and the status and progress of the research, please continue reading on this page .
Raised
$310
Goal
$5,000
2 supporters
Donate
Feed fundraiser card link to Help Find a Cure for Anders' Eyesight
Odylia Therapeutics logo
Fundraiser by Kimberly Payne

Help Find a Cure for Anders' Eyesight

As many of you know, our sweet Anders has a rare genetic eye condition called Leber Congenital Amaurosis (LCA), which is a severe type of cone rod dystrophy. This condition is not only rare but also progressively degenerative, threatening Anders’ vision and overall quality of life. There are several different genes associated with LCA, but the specific gene mutation that affects Anders currently has no treatment. In our search for hope and a potential cure, we learned about Odylia, an 501(c)3 organization that is making remarkable strides in the field of gene therapy specifically targeting the gene that affects Anders’ eyesight. While we are excited by the progress, the reality is that funding for rare diseases is much harder to come by, and grassroots efforts make a big difference in keeping the research moving forward. We humbly request your financial support to aid Odylia in continuing their critical research and development efforts. We understand that there are many causes worthy of support, so we would be incredibly grateful if you could contribute whatever amount you can. Your generosity will not only support cutting-edge research but also provide hope and encouragement to families like ours who are eagerly waiting for a breakthrough. Thank you for considering our request. With sincere gratitude, Joe and Kim Payne
Raised
$45,360
Goal
$50,000
38 supporters
Donate

Donors

  • User or nonprofit avatar
    Leon Nabuurs

    my grandson also deserves a bright future!!

    1
  • Jonathan Bowman-Perks
    2